Left Atrial Appendage Thrombus Formation in a Patient on Dabigatran Therapy Associated With ABCB1 and CES-1 Genetic Defect

• Egile Nagusiak: Zhi-Chun Gu (Egilea), Xiao-Wei Ma (Egilea), Xiao-Yuan Zheng (Egilea), Long Shen (Egilea), Fang-Hong Shi (Egilea), Hao Li (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2018-05-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Dabigatran, directly targeting thrombin, is widely used for the prevention of stroke in nonvalvular atrial fibrillation (NVAF). We reported a rare case of left atrial appendage thrombus formation in a persistent NVAF patient despite the 31 months uninterrupted treatment with dabigatran 110 mg twice...